Q2FY27 Revenue from operations at INR 15,600 Mn up 20% YoY, EBITDA at INR 3,376 Mn up 21% YoY, PBT at INR 2,434 Mn up 38% YoY, PAT at INR 1,818 Mn up 39% YoY.
Hyderabad: November 02nd, 2026: Granules India Ltd., a vertically integrated pharmaceutical company, today announced its...